Abstract
In the present study, Lactobacillus ingluviei ADK10 (Acc. No. JQ395039) from intestinal origin was tested for its probiotic characteristic as well as uremia ameliorating activity on acetaminophen induced uremic rats. The results revealed that L. ingluviei ADK10 was able to tolerate pH 3.0–9.0 and 0.5% bile salt along with good hydrophobicity (67%) and adherence index with Ht-29 cell line on 258/100 cells. It was susceptible to 20 antibiotics. The organism was able to degrade food ingredients, like starch and milk proteins. The strain showed significant growth inhibition of Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Shigella dysentery, Pseudomonas aeruginosa, and Klebsiella pneumoniae (average diameter of 10 mm). The therapeutic potentiality of this probiotic bacterium was tested against acetaminophen induced uremic rats. It was found that supplementation of L. ingluviei ADK10 for 14 days with food reduced severe increase of uremic profiles, such as blood urea (85%), creatinine (68%) and uric acid (41%) in comparison to the uremic rats. Moreover, during the feeding of rats with probiotic strain at a dose of 1×109 bacteria, reduction of enterobacteria in faeces was observed. Our studies indicated that L. ingluviei ADK10 could be used as a health-promoting probiotic along with antiuremic efficacy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Zaher O.A., Abdel-Rahman M.M. & Hafez M.M 2007. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen induced hepatic and renal damage. Toxicology 243: 124–134.
Bliss D.Z., Stein T.P., Schleifer C.R. & Settle R.G. 1996. Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. Am. J. Clin. Nutr. 63: 392–398.
Burtis C.A. & Ashwood E.R. 1999. Tietz Textbook of Clinical Chemistry. 3rd Edn, WB Saunders Company, Philadelphia.
Charteris W.P., Kelly P.M., Morelli L. & Collin J.K. 1998. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lacto bacillus and Bifidobacterium species in the upper human gastrointestinal tract. J. Appl. Microbiol. 84: 759–768.
Chauviere G., Cocoinnier M.H., Kerneis S., Fourniat J. & Servin A.L. 1992. Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. J. Gen. Microbiol. 138: 1689–1696.
Duangjitcharoen Y., Kantachote D., Ongsakul M., Poosaran N. & Chaiyasut C. 2008. Selection of probiotic lactic acid bacteria isolated from fermented plant beverages. Pak. J. Biol. Sci. 11: 652–655.
Erkkilä S. & Petäjä E. 2000. Screening of commercial meat starter cultures at low pH and in the presence of bile salts for potential probiotic use. Meat Sci. 55: 297–300.
Fossati P., Prencipe L. & Berti G. 1980. Use of 3,5-dichloro-2-hydroxy-benzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymetic assay of uric acid in serum and urine. Clin. Chem. 26: 227–231.
Gilliland S.E. & Rich C.N. 1990. Stability during frozen and subsequent refrigerated storage of Lactobacillus acidophilus grown at different pH. J. Dairy Sci. 73: 1187–1192.
Gomes D.A., Souza A.M.L., Lopes R.V., Nunes A.C. & Nicoli R.J. 2006. Comparison of antagonistic ability against enteropathogens by G+ and G-anaerobic dominant components of human fecal microbiota. Folia Microbiol. 51: 141–145.
Gopal P.K., Prasad J., Smart J. & Gill H.S. 2001. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food. Microbiol. 67: 207–216.
Hida M., Aiba Y. & Sawamura S. 1996. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin®, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74: 349–355.
Jacobsen C.N., Rosenfeldt N.V., Hayford A.E. & Moller P.L. 1999. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 65: 4949–4956.
Jain A.K., McLeod I. & Huo C. 2009. When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney. Int. 76: 318–323.
Jones R.J., Hussein H.M. & Zagorec M. 2008. Isolation of lactic acid bacteria with inhibitory activity against pathogens and spoilage organisms associated with fresh meat. Food Microbiol. 25: 228–234.
Mandal A., Paul T., Roy S., Mandal S., Pradhan S., Mondal K.C. & Nandi D.K. 2013a. Effect of newly isolated Lactobacillus ingluviei ADK 10, from chicken intestinal tract on acetaminophen induced oxidative stress in Wistar rats. Indian J. Exp. Biol. 51: 174–180.
Mandal A., Roy S., Das K., Mondal K. & Nandi D. 2013b. In vivo assessment of bacteriotherapy on acetaminophen induced uremic rats. J. Nephrol. 26: 228–236.
Maragkoudakis P.A., Zoumpopoulou G., Miaris C., Kalantzopoulos G., Pot B. & Tsakalidou E. 2006. Probiotic potential of Lactobacillus strains isolated from dairy products. Int. Dairy. J. 16: 189–199.
Musikasang H., Tani A., H-kittikun A. & Maneerat S. 2009. Probiotic potential of lactic acid bacteria isolated from chicken gastrointestinal digestive tract. World J. Microbiol. Biotechnol. 25: 1337–1345.
Natarajan K.R. 1995. Kinetic study of the enzyme urease from Dolichos biflorus. J. Chem. Educ. 72: 556–557.
Olert E.D., Cross B.M. & McWilliam A.A. 1993. Guide to care and use of experimental animals, pp. 1–90. In: Olert E.D. & McWilliam B.M. (eds), Canadian Council on Animal Care, 2nd Edn, Ottawa.
Ouwehand A.C. & Vesterlund S. 2004. 11 Antimicrobial components from lactic acid bacteria, pp. 375–395. In: Salminen S., Ouwehand A. & Von Wright A. (eds) Lactic Acid Bacteria: Microbial and Functional Aspects, 3rd Edn, Marcel Dekker, New York.
Prakash S. & Chang T.M.S. 1996. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2: 883–887.
Rammelsberg M. & Radler F. 1990. Antibacterial polypeptides of Lactobacillus species. J. Appl. Bacteriol. 69: 177–184.
Ranganathan N., Patel B.G. & Ranganathan P. 2006. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J. 52: 70–79.
Rijnaarts H.H.M., Norde W., Bouwer E.J., Lyklema J. & Zehnder A.J.B. 1993. Bacterial adhesion under static and dynamic conditions. Appl. Environ. Microbiol. 59: 3255–3265.
Sabbagh M., Rick W. & Schneide R.S. 1988. A kinetic method for the direct determination of creatinine in serum with 3,5-dinitrobenzoic acid without deproteinization. J. Clin. Chem. Clin. Biochem. 26: 15–24.
Sparks R.E. 1979. Review of gastrointestinal perfusion in the treatment of uremia. Clin. Nephrol. 11: 81–85.
Thapa N., Pal J. & Tamang J.P. 2004. Microbial diversity in ngari, hentak and tungtap, fermented fish products of North-East, India. World J. Microbiol. Biotechnol. 20: 599–607.
Author information
Authors and Affiliations
Corresponding author
Additional information
Based on a contribution presented at the International Conference on Industrial Biotechnology (ICIB-2012), November 21–23, 2012, Punjabi University, Patiala (Pb.), India
Rights and permissions
About this article
Cite this article
Mandal, A., Paul, T., Roy, S. et al. Therapeutic potential of Lactobacillus ingluviei ADK10, a newly established probiotic organism against acetaminophen induced uremic rats. Biologia 68, 1072–1078 (2013). https://doi.org/10.2478/s11756-013-0278-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11756-013-0278-z